(EYES), (EARS), now Nose & Throat, Buy (XENT) Intersect ENT Inc.

Health Master

Junior member
19 1
Ears, Nose, Throat Devices Market to reach $26BB, bio-absorbable devices such as Propel & Sinuva fastest growing segment.

(XENT) capturing 5% of market realize $1.3BB in revenues/ 32MM Shares = 40$ per share in Revenue, at comp. 10X Sales= $200 per share
AdBlock Detected

We get it, advertisements are annoying!

But it's thanks to our sponsors that access to Trade2Win remains free for all. By viewing our ads you help us pay our bills, so please support the site and disable your AdBlocker.

I've Disabled AdBlock